UBS ends price stabilisation for Foundation Healthcare IPO

SGX Filings
08/08

UBS AG, Singapore Branch announced it has completed price stabilisation measures for the initial public offering of Foundation Healthcare Holdings Limited.

The stabilising manager disclosed that, up to Aug, 07 2026, it had bought a total of 21.25 million shares in Foundation Healthcare Holdings Limited and has now ceased all stabilising actions.

UBS added that the over-allotment option granted by SeaTown Private Capital Master Fund to the joint bookrunners and underwriters—Jefferies Singapore Limited, Oversea-Chinese Banking Corporation Limited, UBS AG Singapore Branch, DBS Bank Ltd. and United Overseas Bank Limited—was partially exercised for 3.03 million shares to cover the remaining balance of the 24.28 million shares previously over-allotted in connection with the offering.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10